title: ﻿Fighting against infectious diseases in China.
abstract: Dr. Yin started his research on infectious disease prevention in the 1980s. In 1985, Dr. Yin sucessfully isolated the hepatitis A virus, after which, in 2002, he developed the first proprietary inactivated hepatitis A vaccine in China and soon launched it into the China market. Led by Dr. Yin, Sinovac successfully developed the vaccine prducts against SARS, H5N1, H1N1, hepatitis A and B and infleunza. Currently, Sinovac is working on the R&D of EV71 vaccine against hand, foot and mouth disease, and pneumococcal conjugate vaccine. Sinovac aims to provide Chinese children with international quality vaccines, and provide children in the world with vaccines made in China.
authors.affiliation: Sinovac, Beijing, China. yinwd@sinovac.com
authors.forename: Weidong
authors.initials: W
authors.lastname: Yin
mesh_terms: D002648:Child; D002681:China / Q000453:epidemiology; D003140:Communicable Disease Control; D030041:Hepatitis A virus / Q000276:immunology; D006801:Humans; D053118:Influenza A Virus, H1N1 Subtype / Q000276:immunology; D053124:Influenza A Virus, H5N1 Subtype / Q000276:immunology; D012106:Research; D045473:Severe acute respiratory syndrome-related coronavirus / Q000276:immunology; D015164:Vaccines, Inactivated; D014765:Viral Vaccines; D014777:Virus Diseases / Q000517:prevention & control*
chemical_list: D015164:Vaccines, Inactivated; D014765:Viral Vaccines